Outlook Therapeutics (OTLK) News Today → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free OTLK Stock Alerts $8.19 -0.01 (-0.12%) (As of 03:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBest's Market Segment Report: AM Best Revises Outlook on London Market Insurance Segment to Positivefinance.yahoo.com - April 22 at 1:21 PMWGA Releases New Housing Finance Outlookmarkets.businessinsider.com - April 22 at 1:21 PMOutlook: How to set up breaks between your meetingsmsn.com - April 22 at 1:21 PMOutlook Therapeutics, Inc. (OTLK)finance.yahoo.com - April 21 at 8:02 PMWorld Polyethylene High Density (HDPE) Market Outlook 2024-2033: Capacities, Production, Consumption, Trade Statistics, and Pricesfinance.yahoo.com - April 18 at 6:25 PMBosch Flags Further Cost Cuts After Giving 'Subdued' Outlook for 2024usnews.com - April 18 at 6:25 PMOutlook Therapeutics® Announces Closing of Private Placement of $5.0 Millionglobenewswire.com - April 15 at 4:15 PMBiotech on a Budget: 7 Stocks Under $10 With Huge Potentialinvestorplace.com - April 15 at 12:54 PMOutlook Therapeutics (NASDAQ:OTLK) versus Vigil Neuroscience (NASDAQ:VIGL) Head-To-Head Contrastamericanbankingnews.com - April 15 at 1:14 AMUS Consumer Sentiment Falls Slightly as Outlook for Inflation Worsensmsn.com - April 14 at 9:03 AMMicrosoft Outlook 2010's Default Profile Pic Was Based on Bill Gates' 1977 Mug Shot?msn.com - April 14 at 9:03 AMFed's Williams: Outlook is uncertain, Fed must be data-dependentfxstreet.com - April 11 at 6:05 PMStock Market Today: Wall Street Falls After Hot Inflation Data Burns Hopes for a June Rate Cutmsn.com - April 11 at 1:44 AMBitdefender now has identity protection for Gmail and Outlookmsn.com - April 11 at 1:44 AMInsiders are Piling into These 10 Healthcare Stocks in 2024finance.yahoo.com - April 10 at 3:44 PMUsers Complain Gmail Blocks Email From Microsoft Outlook—Here’s The Fixforbes.com - April 3 at 3:14 PMOutlook.com trips over Google's spam blocking rulesmsn.com - April 3 at 3:14 PMYezan Munther Haddadin Purchases 1,882 Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK) Stockinsidertrades.com - March 30 at 7:48 AMBTIG upgrades Outlook Therapeutics stock to buy, cites ONS-5010 successuk.investing.com - March 29 at 8:32 PMOutlook Therapeutics, Inc. (NASDAQ:OTLK) Director Yezan Munther Haddadin Acquires 1,882 Sharesmarketbeat.com - March 29 at 12:10 PMOutlook Therapeutics, Inc. (NASDAQ:OTLK) Short Interest Down 93.3% in Marchmarketbeat.com - March 27 at 10:15 PMBuy Rating for Outlook Therapeutics: Promising FDA Developments and Strong Financial Position Support $50 Price Targetmarkets.businessinsider.com - March 27 at 3:13 PMOutlook Therapeutics shares rise after 'buy' rating from BTIGmsn.com - March 27 at 3:13 PMOutlook Therapeutics (NASDAQ:OTLK) Upgraded by BTIG Research to Buymarketbeat.com - March 27 at 8:30 AMOutlook Therapeutics: Buy Rating Affirmed Amid Positive European Developments and Anticipated U.S. Market Successmarkets.businessinsider.com - March 25 at 7:36 PMHC Wainwright Raises Outlook Therapeutics (NASDAQ:OTLK) Price Target to $30.00marketbeat.com - March 25 at 8:48 AMBuy Rating Affirmed for Outlook Therapeutics: European Endorsement and Pivotal US Study Progress Signal Strong Market Potentialmarkets.businessinsider.com - March 25 at 5:33 AMOutlook Therapeutics Surges On Positive CHMP Opinion For ONS-5010nasdaq.com - March 24 at 7:33 PMWhy Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?msn.com - March 22 at 3:36 PMOutlook Therapeutics Shares Rise Premarket on CHMP Backing of Wet AMD Drugmarketwatch.com - March 22 at 10:35 AMCanopy Growth, Capricor Therapeutics, GT Biopharma among healthcare moversmsn.com - March 22 at 10:35 AMOutlook Therapeutics Receives Positive CHMP Opinion For ONS-5010 To Treat Wet AMDmarkets.businessinsider.com - March 22 at 10:35 AMmarketbeat.com - March 22 at 9:33 AMOutlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMDglobenewswire.com - March 22 at 7:35 AMResearch Analysts Issue Forecasts for Outlook Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:OTLK)marketbeat.com - March 21 at 8:04 AMBuy Rating Affirmed for Outlook Therapeutics Amidst Strong Financial Positioning and Advancing Clinical Trialsmarkets.businessinsider.com - March 19 at 5:22 AMOutlook Therapeutics® Announces Closing of Private Placement of up to $159 Millionglobenewswire.com - March 18 at 5:10 PMGlobal Sustainable Packaging Market Outlook & Forecast 2024-2029: Biodegradable Innovations and E-Commerce Driving Growthfinance.yahoo.com - March 18 at 9:20 AMResearch Analysts Set Expectations for Outlook Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:OTLK)marketbeat.com - March 18 at 1:44 AMBITmarkets' New Crypto Outlook Adresses Bitcoin Halving and Other Milestones of 2024markets.businessinsider.com - March 17 at 12:31 PMmarketbeat.com - March 15 at 3:25 PMOutlook Therapeutics (NASDAQ:OTLK) Stock Price Up 5.4%marketbeat.com - March 15 at 12:37 PMmarketbeat.com - March 15 at 10:08 AM2024 Automotive Tapes Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2023 to 2031uk.finance.yahoo.com - March 14 at 3:41 PMOutlook Therapeutics (NASDAQ:OTLK) Trading Down 5.6%marketbeat.com - March 14 at 12:47 PMEQS-News: Management Board Gives Positive Outlook for FY 2023/2024markets.businessinsider.com - March 14 at 10:40 AMOutlook Therapeutics Inc (41ON.MU)sg.finance.yahoo.com - March 14 at 10:40 AMmarketbeat.com - March 14 at 6:11 AMThe end of classic Outlook for Windows is coming. Are you ready?msn.com - March 13 at 6:28 PMOutlook Therapeutics falls on 1-for-20 reverse stock splitmsn.com - March 13 at 6:28 PM Get Outlook Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OTLK and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry OTLK Media Mentions By Week OTLK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OTLK News Sentiment▼0.130.43▲Average Medical News Sentiment OTLK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OTLK Articles This Week▼63▲OTLK Articles Average Week Get Outlook Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OTLK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vigil Neuroscience News Today Cardiol Therapeutics News Today aTyr Pharma News Today bluebird bio News Today BioAtla News Today Sangamo Therapeutics News Today Zura Bio News Today Agenus News Today Omega Therapeutics News Today DBV Technologies News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OTLK) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersPentagon contract could send this $2 AI stock soaringBehind the MarketsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
